[
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock outperforms competitors despite losses on the day",
    "summary": "Boston Scientific Corp. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=34f960a8973da033907449871f905eb50ef3378d7da794a342afcc9f6e57db12",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732898400,
      "headline": "Boston Scientific Corp. stock outperforms competitors despite losses on the day",
      "id": 131777670,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=34f960a8973da033907449871f905eb50ef3378d7da794a342afcc9f6e57db12"
    }
  },
  {
    "ts": null,
    "headline": "Why Is Zimmer (ZBH) Up 4.8% Since Last Earnings Report?",
    "summary": "Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
    "url": "https://finnhub.io/api/news?id=f667970709ea0f7d68f928a39f93848e05f5dc0a36080eb663747e2cd206b740",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732897923,
      "headline": "Why Is Zimmer (ZBH) Up 4.8% Since Last Earnings Report?",
      "id": 131711203,
      "image": "https://media.zenfs.com/en/zacks.com/3cb5117fc22f5e37890d1860dcd61f9f",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.",
      "url": "https://finnhub.io/api/news?id=f667970709ea0f7d68f928a39f93848e05f5dc0a36080eb663747e2cd206b740"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Mid Cap Growth Managed Account Q3 2024 Commentary",
    "summary": "Janus Henderson Mid Cap Growth Managed Account Portfolio returned 8.58% \n(gross) for Q3 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=3ff2a6f26238d0baa446940c2668e83efb92bc6e34141d338b27c340c2af776f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732850400,
      "headline": "Janus Henderson Mid Cap Growth Managed Account Q3 2024 Commentary",
      "id": 131701720,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2169953245/image_2169953245.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Janus Henderson Mid Cap Growth Managed Account Portfolio returned 8.58% \n(gross) for Q3 2024. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=3ff2a6f26238d0baa446940c2668e83efb92bc6e34141d338b27c340c2af776f"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Global Life Sciences Diversified ADR Managed Account Q3 2024 Commentary",
    "summary": "The Janus Henderson Global Life Sciences Diversified ADR Managed AccountÂ Portfolio returned 5.74% (gross) for Q3 2024. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=d13820debe5090781df5f64d03a4e6366609fc54e420fcea29eb851f7981fff8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732841400,
      "headline": "Janus Henderson Global Life Sciences Diversified ADR Managed Account Q3 2024 Commentary",
      "id": 131700113,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1633433467/image_1633433467.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "The Janus Henderson Global Life Sciences Diversified ADR Managed AccountÂ Portfolio returned 5.74% (gross) for Q3 2024. Click here to read the full commentary.",
      "url": "https://finnhub.io/api/news?id=d13820debe5090781df5f64d03a4e6366609fc54e420fcea29eb851f7981fff8"
    }
  }
]